Document type: drug_safety_update
There are 859 pages with document type ‘drug_safety_update’ in the GOV.UK search index.
Rendering apps
This document type is rendered by:
Supertypes
| Type | Group |
|---|---|
| User journey | thing |
| Email document type | other |
| Government document type | other |
| Content Purpose Subgroup | updates_and_alerts |
| Content Purpose Supergroup | news_and_communications |
Content schemas
This document type is allowed by the schema:
Example pages
- GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases
- Isotretinoin – changes to prescribing guidance and additional risk minimisation measures
- Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
- Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs
- Rybelsus ® (semaglutide tablets): transition to new formulation and risk of medication error
- Mesalazine and idiopathic intracranial hypertension
- Topiramate (Topamax): introduction of new safety measures, including a Pregnancy Prevention Programme
- Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate
- Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk
- Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions